Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-10-20

Clinical Trial Update: Hemodynamic Effects of Rolofylline in the Treatment of Patients With Heart Failure (7418-503) [Phase 2]

View source ↗

Summary

This entry reports the completion of a Phase 2 trial evaluating the hemodynamic effects of Rolofylline in patients with heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rolofylline (rolofylline)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Heart Failure | Phase 2 | Status: COMPLETED